Anti-HIV medication

Anti-HIV medication

C002/9912 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 14.7MB

Downloadable file size: 896.8KB

Price image Pricing

Please login to use the price calculator


Caption: Bottles containing the anti-HIV medication T-1249 developed by the Trimeris Biopharmaceutical Company. T-1249 is in a category of HIV medicines called fusion inhibitors, or entry inhibitors. Entry inhibitors are a new class of anti-HIV drugs none of which have yet been approved for the treatment of HIV. T-1249 binds to a protein on HIV's surface called gp41. Once this occurs, HIV cannot bind with the surface of T-cells, thus preventing the virus from infecting healthy cells.

Release details: Model release not required. Property release not required.

Keywords: acquired immune deficiency syndrome, anti-hiv medication, drug, drugs, fusion inhibitor, fusion inhibitors, hiv, hiv drug, hiv drugs, hiv virus, horizontal, human immunodeficiency virus, medication, medications, person, t-1240

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.